Dr Charlotte Toomes

Charlotte is an early-career researcher in the Multiple Myeloma Translational Research Laboratory at the Flinders Centre for Innovation in Cancer. She has recently joined Flinders University after undertaking her PhD studies through the University of Adelaide at the South Australian Health and Medical Research Institute (SAHMRI). Her work with the Acute Lymphoblastic Leukaemia (ALL) Research Group investigated the efficacy of targeted therapies and molecular mechanisms of drug resistance within a subtype of ALL associated with poor prognosis. Charlotte's current research now focuses on identifying novel prognostic biomarkers for multiple myeloma to rapidly identify high-risk patients and guide appropriate treatment regimens.